Skip to content

A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG

A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG

Status
Not yet recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07101367
Enrollment
60
Registered
2025-08-03
Start date
2025-09-01
Completion date
2026-08-31
Last updated
2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Postoperative Complications, Systemic Inflammatory Response Syndrome

Brief summary

A comparison between precedex versus solumedrol as anti-inflammatory stress response inhibitors in patients undergoing on-pump CABG using different inflammatroy response parameters and the outcome of the drugs on the cognitive and cardiac status post extubation

Interventions

DRUGNormal saline

After induction of anesthesia give 10 ml of normal saline then followed by infusion of normal saline till extubation of patient in ICU

DRUGDexmedetomidine

After induction of anesthesia give loading dose of precedex 1 mcg/kg diluted in 10 ml normal saline then attach syringe pump of precedex infusion of 0.5mcg/kg/hr till extubation in ICU

DRUGMethylprednisolone

After induction of anesthesia give solumedrol of a dose 10mg/kg diluted in 10ml of normal saline followed by a normal saline infusion till the extubation of the patient in the ICU

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Randomized Double blinded clinical trial

Intervention model description

Control group without any medications Dexmedetomidine group Methylprednisolone group

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 21-60 years. 2. Sex: Both sexes. 3. American Society of Anaesthesiologists (ASA) Physical Status Class II, and III. 4. Scheduled for CABG on cardio-pulmonary bypass.

Exclusion criteria

1. Declining to give a written informed consent. 2. History of allergy to the medications used in the study. 3. Psychiatric disorders. 4. Significant cognitive dysfunction. 5. American Society of Anesthesiologists (ASA) Physical Status Class IV. 6. Chronic liver or kidney disease. 7. Poor systolic function ( Ejection fraction \< 40% ). 8. Pregnancy. 9. Redo CABG. 9.Infection during the week preceding surgery white blood cell count over 11,000 mm3 10.Pre-operative use of antibiotics or corticosteroids.

Design outcomes

Primary

MeasureTime frameDescription
Induced inflammatory responseFirst 24 hours post cardio-pulmonary bypassEffect of both drugs on attenuating induced inflammatory response

Secondary

MeasureTime frameDescription
Cognitive functionFirst 24 hours post cardio-pulmonary bypassAssesment of post operative cognitive function and occurnce of post operative delerium using CAM-ICU score

Countries

Egypt

Contacts

Primary ContactAssem Abourawash, Masters
assemahmed999@gmail.com00201064013278

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026